We are live on ! Find out more
NDSI

Newman Dignan & Sheerar Inc Portfolio holdings

AUM $523M
1-Year Est. Return 26.16%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+26.16%
3 Year Est. Return
+73.46%
5 Year Est. Return
+76.54%
10 Year Est. Return
+322.08%
AUM
$139M
AUM Growth
-$1.21M
Cap. Flow
-$18.2M
Cap. Flow %
-13.11%
Top 10 Hldgs %
28.8%
Holding
160
New
14
Increased
51
Reduced
62
Closed
16
Avg Time Held
6.1 quarters
Top 10 Avg Time Held
3.7 quarters
Top 20 Avg Time Held
5.3 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 38.01%
2 Healthcare 13.9%
3 Technology 12.3%
4 Financials 9.46%
5 Industrials 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SCHG icon
1
Schwab US Large-Cap Growth ETF
SCHG
$65.3B
$6.62M 4.77%
987,040
-31,000
-3% -$211K
2013 Q2
8 quarters
SCHV icon
2
Schwab US Large-Cap Value ETF
SCHV
$15.4B
$5.57M 4.01%
388,188
-8,088
-2% -$119K
2013 Q2
8 quarters
SCHA icon
3
Schwab U.S Small- Cap ETF
SCHA
$21.8B
$4.43M 3.19%
308,168
+1,372
+0.4% +$19.9K
2013 Q2
8 quarters
GE icon
4
GE Aerospace
GE
$321B
$4.03M 2.9%
31,632
-285
-0.9% -$37K
2013 Q2
8 quarters
AAPL icon
5
Apple
AAPL
$4.95T
$3.68M 2.65%
117,496
+1,608
+1% +$51.4K
2013 Q2
8 quarters
SCHD icon
6
Schwab US Dividend Equity ETF
SCHD
$111B
$3.65M 2.63%
285,927
-7,203
-2% -$95.3K
2013 Q2
8 quarters
JNJ icon
7
Johnson & Johnson
JNJ
$635B
$3.53M 2.54%
36,176
+71
+0.2% +$7.11K
2013 Q2
8 quarters
MRK icon
8
Merck
MRK
$358B
$2.95M 2.13%
54,343
+1,209
+2% +$67.8K
2013 Q2
8 quarters
IJH icon
9
iShares Core S&P Mid-Cap ETF
IJH
$123B
$2.78M 2%
92,770
+3,155
+4% +$96.2K
2013 Q2
8 quarters
SCHX icon
10
Schwab US Large- Cap ETF
SCHX
$75.2B
$2.75M 1.98%
334,290
+6,834
+2% +$57.4K
2013 Q2
8 quarters
INTC icon
11
Intel
INTC
$536B
$2.66M 1.91%
87,423
+922
+1% +$29.8K
2013 Q2
8 quarters
CVS icon
12
CVS Health
CVS
$111B
$2.62M 1.89%
24,985
-100
-0.4% -$10.2K
2013 Q2
8 quarters
IJR icon
13
iShares Core S&P Small-Cap ETF
IJR
$104B
$2.56M 1.84%
43,360
+2,858
+7% +$169K
2013 Q2
8 quarters
XOM icon
14
ExxonMobil
XOM
$708B
$2.45M 1.76%
29,413
-857
-3% -$73.7K
2013 Q2
8 quarters
MSFT icon
15
Microsoft
MSFT
$4.01T
$2.44M 1.75%
55,160
+540
+1% +$24.6K
2013 Q2
8 quarters
SDY icon
16
State Street SPDR S&P Dividend ETF
SDY
$20.9B
$2.41M 1.73%
31,598
-1,141
-3% -$89.4K
2013 Q3
7 quarters
BMY icon
17
Bristol-Myers Squibb
BMY
$117B
$2.38M 1.72%
35,845
+870
+2% +$57.3K
2013 Q2
8 quarters
PG icon
18
Procter & Gamble
PG
$355B
$2.35M 1.69%
30,018
+148
+0.5% +$11.9K
2013 Q2
8 quarters
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.25T
$2.33M 1.68%
89,260
+1,841
+2% +$49.3K
2013 Q2
8 quarters
PEP icon
20
PepsiCo
PEP
$173B
$2.18M 1.57%
23,385
-188
-0.8% -$18K
2013 Q2
8 quarters
VZ icon
21
Verizon
VZ
$177B
$1.73M 1.25%
37,195
-138
-0.4% -$6.75K
2013 Q2
8 quarters
WFC icon
22
Wells Fargo
WFC
$253B
$1.69M 1.21%
29,974
-400
-1% -$22.3K
2013 Q2
8 quarters
AMGN icon
23
Amgen
AMGN
$225B
$1.62M 1.17%
10,544
-93,453
-90% -$15M
2013 Q2
8 quarters
SCHM icon
24
Schwab US Mid-Cap ETF
SCHM
$14.6B
$1.57M 1.13%
110,604
+11,679
+12% +$169K
2013 Q2
8 quarters
COF icon
25
Capital One
COF
$124B
$1.54M 1.11%
17,544
+2,175
+14% +$183K
2013 Q2
8 quarters

Similar funds

Newman Dignan & Sheerar Inc's Q2 2015 Portfolio in Review

As of Q2 2015, Newman Dignan & Sheerar Inc held 160 positions worth $139M, down 0.86% from $140M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Newman Dignan & Sheerar Inc withdrew a net $18.2M in Q2 2015, closing 16 positions and reducing 62 holdings. Its most notable exit was Medtronic, an estimated $1.64M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Newman Dignan & Sheerar Inc opened a new position in Molson Coors Class A worth $778K.

  • Newman Dignan & Sheerar Inc's largest Q2 2015 buy was Molson Coors Class A: 11,145 shares worth $778K.
  • Newman Dignan & Sheerar Inc added most to Capital One in Q2 2015, an estimated $183K increase.
  • Newman Dignan & Sheerar Inc's biggest Q2 2015 reduction was Amgen, cutting an estimated $15M.
  • Newman Dignan & Sheerar Inc fully exited Medtronic in Q2 2015, selling an estimated $1.64M.
  • Newman Dignan & Sheerar Inc's ten largest holdings make up 29% of its $139M portfolio in Q2 2015.
  • Newman Dignan & Sheerar Inc opened 14 new positions and closed 16 in Q2 2015.
  • Newman Dignan & Sheerar Inc's portfolio value fell 0.86% quarter-over-quarter to $139M.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2015, filed 15 Jul 2015.